This article was funded by paid subscribers of The Dissenter Newsletter, a project of Shadowproof. Become a monthly subscriber to help us continue our independent journalism.

The False Claims Act in the United States allows individuals with evidence of fraud against government agencies to bring lawsuits as qui tam whistleblowers. They can bring a case even if the US Justice Department has no interest in fighting the alleged corruption.

But on June 21, Courthouse News reported that the US Supreme Court will determine whether the government has the authority to dismiss a whistleblower lawsuit brought under the False Claims Act when the government has declined to intervene in the case. In other words, the Supreme Court could help corporations shut down independent whistleblower lawsuits that the Justice Department does not want to pursue.

Health care and pharmaceutical corporations, along with their lobbying networks, have ramped up pressure in recent years to stifle the effectiveness of the False Claims Act in holding their industry accountable and prevent the law’s expansion.

Under President Donald Trump, the National Whistleblower Center reported in 2018 that US government recoveries under the law hit a “ten-year low.” Nearly $2.9 billion was recovered, but only $767 million of that money was a result of lawsuits by the government. Whistleblower lawsuits, however, yielded over $2.1 billion.

A network of dark money has transformed the Supreme Court into an illegitimate and...

Read Full Story: https://shadowproof.com/2022/06/28/us-supreme-court-to-review-whistleblower-l...